Difference between revisions of "Phosphatase Subfamily DSP6"

From PhosphataseWiki
Jump to: navigation, search
Line 6: Line 6:
  
 
=== Domain ===
 
=== Domain ===
 
+
DSP6 subfamily has two domains: rhodanese domain and phosphatase domain. Rhodanese domain mediates interaction with MAP kinases (often ERK). Rhodanese domain of DSP6 also has two conserved Leu-rich nuclear export signals <cite>Karlsson04</cite> (particular Figure 5 and Figure 11). Binding to MAP kinases induces conformation change in phosphatase domain, which can increase the phosphatase activity <cite>Stewart99</cite>.
  
 
=== Function ===
 
=== Function ===
  
 
====== DUSP6 (MKP3/PYST1) ======
 
====== DUSP6 (MKP3/PYST1) ======
 +
DUSP6 preferentially dephosphorylates ERK <cite>Muda96, Groom96, Kim03</cite>, which resulted from that DUSP6 binds to ERK but not p38 or JNK. The interaction is mediated by rhodanese domain (or kinase interaction motif embedded in rhodanese domain?) <cite>Muda98</cite>. Later study has shown DUSP6 is ERK1/2-specific, as it does not inactive ERK5 <cite>Arkell08</cite>.
 +
 +
As a negative regulator of ERK, DUSP6 is proposed to be tumor suppressor. DUSP6 expression was down-regulated through hypermethylation at enhancer in some pancreatic cell lines and pancreatic cancer tissues <cite>Furukawa98, Xu05</cite>. But, DUSP6 was up-regulated in endometrial adenocarcinomas <cite>Zhang13</cite>, thyroid carcinoma <cite>Lee12, DeglInnocenti13</cite>, and glioblastomas <cite>Messina11</cite>. Meanwhile, DUSP6 upregulation induced by angiotensin II mediates endothelial cell apoptosis <cite>Rossig02</cite>. (note: DUSP6 upregulation in cancer may be the response to suppress carcinogenesis?)
 +
 +
Like DUSP2, DUSP4 and DUSP4 of DSP1 subfamily, DUSP6 is phosphorylated by ERK ('''note: same positions?''').
  
 +
Nitric oxide down-regulates MKP-3 mRNA levels <cite>Rossig00</cite>.
  
 
====== DUSP7 (MKPX/PYST2) ======
 
====== DUSP7 (MKPX/PYST2) ======
Line 25: Line 31:
 
=== References ===
 
=== References ===
 
<biblio>
 
<biblio>
 +
#Arkell08 pmid=18280112
 +
#DeglInnocenti13 pmid=23132790
 
#Dickinson11 pmid=21908610
 
#Dickinson11 pmid=21908610
 +
#Dowd98 pmid=9788880
 +
#Furukawa98 pmid=9858808
 +
#Groom96 pmid=8670865
 +
#Karlsson04 pmid=15269220
 +
#Kim03 pmid=14690430
 +
#Lee12 pmid=22535643
 
#Levy-Nissenbaum03a pmid=14576828
 
#Levy-Nissenbaum03a pmid=14576828
 
#Levy-Nissenbaum03b pmid=14674243
 
#Levy-Nissenbaum03b pmid=14674243
 
#Levy-Nissenbaum04 pmid=14603440
 
#Levy-Nissenbaum04 pmid=14603440
 
#Liu07 pmid=18006813
 
#Liu07 pmid=18006813
 +
#Messina11 pmid=
 
#Muda96 pmid=8626780
 
#Muda96 pmid=8626780
 
#Muda97 pmid=9030581
 
#Muda97 pmid=9030581
 +
#Muda98 pmid=9535927
 +
#Rossig00 pmid=10846176
 +
#Rossig02 pmid=11998972
 +
#Stewart99 pmid=10048930
 
#Wu11 pmid=21943117
 
#Wu11 pmid=21943117
 +
#Xu05 pmid=15824892
 +
#Zhang13 pmid=23419500
 
</biblio>
 
</biblio>

Revision as of 00:16, 7 March 2015

Phosphatase Classification: Fold CC1: Superfamily CC1: Family DSP: Subfamily DSP6

Evolution

Domain

DSP6 subfamily has two domains: rhodanese domain and phosphatase domain. Rhodanese domain mediates interaction with MAP kinases (often ERK). Rhodanese domain of DSP6 also has two conserved Leu-rich nuclear export signals [1] (particular Figure 5 and Figure 11). Binding to MAP kinases induces conformation change in phosphatase domain, which can increase the phosphatase activity [2].

Function

DUSP6 (MKP3/PYST1)

DUSP6 preferentially dephosphorylates ERK [3, 4, 5], which resulted from that DUSP6 binds to ERK but not p38 or JNK. The interaction is mediated by rhodanese domain (or kinase interaction motif embedded in rhodanese domain?) [6]. Later study has shown DUSP6 is ERK1/2-specific, as it does not inactive ERK5 [7].

As a negative regulator of ERK, DUSP6 is proposed to be tumor suppressor. DUSP6 expression was down-regulated through hypermethylation at enhancer in some pancreatic cell lines and pancreatic cancer tissues [8, 9]. But, DUSP6 was up-regulated in endometrial adenocarcinomas [10], thyroid carcinoma [11, 12], and glioblastomas [13]. Meanwhile, DUSP6 upregulation induced by angiotensin II mediates endothelial cell apoptosis [14]. (note: DUSP6 upregulation in cancer may be the response to suppress carcinogenesis?)

Like DUSP2, DUSP4 and DUSP4 of DSP1 subfamily, DUSP6 is phosphorylated by ERK (note: same positions?).

Nitric oxide down-regulates MKP-3 mRNA levels [15].

DUSP7 (MKPX/PYST2)

DUSP7 is constitutively expressed in a wide variety of human cell lines. DUSP7 is predominantly cytosolic when expressed in COS-1 cells. In common with other members of DSP6 subfamily, DUSP7 shows substrate selectivity ERK > p38 = JNK. DUSP7 binds ERK in vivo. Both ERK and JNK activate DUSP7 phosphatase activity in vitro [16].

DUSP7 has at least two isoforms. The longer isoform is constitutively highly expressed in myeloid leukemia and other malignant cells [17, 18, 19].

DUSP9 (MKP4)

DUSP6 blocks activation of MAP kinases with the selectivity ERK > p38 = JNK. Same as other members in the subfamily, it locates in cytosol [20, 21]. DUSP9 is unique among these cytoplasmic MKPs in containing a conserved PKA consensus phosphorylation site (55)RRXSer-58 immediately adjacent to the kinase interaction motif. DUSP9 is phosphorylated on Ser-58 by PKA in vitro, and phosphorylation abrogates the binding of DUSP9 to both ERK2 and p38alpha MAP kinases [22].

Decreased expression of DUSP-9 is associated with poor prognosis in clear cell renal cell carcinomas [23].

References

Error fetching PMID 18280112:
Error fetching PMID 23132790:
Error fetching PMID 21908610:
Error fetching PMID 9788880:
Error fetching PMID 9858808:
Error fetching PMID 8670865:
Error fetching PMID 15269220:
Error fetching PMID 14690430:
Error fetching PMID 22535643:
Error fetching PMID 14576828:
Error fetching PMID 14674243:
Error fetching PMID 14603440:
Error fetching PMID 18006813:
Error fetching PMID 8626780:
Error fetching PMID 9030581:
Error fetching PMID 9535927:
Error fetching PMID 10846176:
Error fetching PMID 11998972:
Error fetching PMID 10048930:
Error fetching PMID 21943117:
Error fetching PMID 15824892:
Error fetching PMID 23419500:
  1. Error fetching PMID 15269220: [Karlsson04]
  2. Error fetching PMID 10048930: [Stewart99]
  3. Error fetching PMID 8626780: [Muda96]
  4. Error fetching PMID 8670865: [Groom96]
  5. Error fetching PMID 14690430: [Kim03]
  6. Error fetching PMID 9535927: [Muda98]
  7. Error fetching PMID 18280112: [Arkell08]
  8. Error fetching PMID 9858808: [Furukawa98]
  9. Error fetching PMID 15824892: [Xu05]
  10. Error fetching PMID 23419500: [Zhang13]
  11. Error fetching PMID 22535643: [Lee12]
  12. Error fetching PMID 23132790: [DeglInnocenti13]
  13. pmid= [Messina11]
  14. Error fetching PMID 11998972: [Rossig02]
  15. Error fetching PMID 10846176: [Rossig00]
  16. Error fetching PMID 9788880: [Dowd98]
  17. Error fetching PMID 14576828: [Levy-Nissenbaum03a]
  18. Error fetching PMID 14674243: [Levy-Nissenbaum03b]
  19. Error fetching PMID 14603440: [Levy-Nissenbaum04]
  20. Error fetching PMID 9030581: [Muda97]
  21. Error fetching PMID 18006813: [Liu07]
  22. Error fetching PMID 21908610: [Dickinson11]
  23. Error fetching PMID 21943117: [Wu11]
All Medline abstracts: PubMed | HubMed